Home / Crime and Justice / Novartis Settles Lacks Family Lawsuit Over Immortal Cells
Novartis Settles Lacks Family Lawsuit Over Immortal Cells
24 Feb
Summary
- Novartis resolved claims of profiting from Henrietta Lacks' cells.
- The confidential deal with Lacks' estate is part of a larger legal fight.
- HeLa cells, derived from Lacks, have aided research from polio to HIV.

Novartis recently reached a confidential settlement with the estate of Henrietta Lacks, addressing allegations of profiting from her famously resilient cells without proper consent.
This agreement is one part of an escalating legal battle initiated by Lacks' heirs against various pharmaceutical companies. The family contends these companies unjustly benefited from the 'HeLa' cell line, derived from Lacks' tissue without her knowledge or permission when she sought treatment for cervical cancer in 1951.


